COMBINATION THERAPY FOR CANCER

• 收藏
• 分享

专利权人:

IMCLONE LLC;MERCK SHARP &； DOHME CORP.

发明人:

Maciej Wojciech GIL,Raffael KUREK

申请号：

US16330128

公开号：

US20190233523A1

申请日:

2017.09.07

申请国别(地区):

US

年份:

2019

代理人:

摘要：

The present invention provides preparation of medicaments for use in treating and methods of treating cancer, in particular, non-small cell lung cancer, comprising an anti-EGFR antibody, preferably necitumumab, in combination with an anti-PD-1 antibody, preferably pembrolizumab.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/